Supplementation Improves QOL in Iron Deficiency With Solid Tumors
Researchers sought to determine whether iron supplementation would improve quality of life and functional capacity of patients with cancer who develop iron deficiency.
Researchers sought to determine whether iron supplementation would improve quality of life and functional capacity of patients with cancer who develop iron deficiency.
A retrospective, cross-sectional study of 200 patients with cancer was conducted to determine the potential value of these interventions in the oncology setting.
Researchers sought to determine if a virtual, group-based rehabilitation program could improve perception of cognitive function, behavior, and feelings of loneliness in patients with cancer.
Researchers surveyed patients with cancer to determine whether cancer pain self-management support meets their needs and preferences during the transition to home and self-care.
Treatment of fatigue related to high-grade glioma using armodafinil did not show a meaningful benefit over placebo in a phase 3 trial.
Researchers sought to determine the effects of commonly used interventions on 2 significant symptoms experienced by patients with leukemia.
The guideline focuses on managing treatment of cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome in patients undergoing CAR-T therapy for hematologic cancers.
A head-to-head comparison was conducted to determine the safety and efficacy of fosnetupitant with fosaprepitant in combination with palonosetron and dexamethasone.
This review discusses the importance of an early diagnosis of C diff infection in patients who have undergone HSCT and the recommended treatment options.
Three case reports describe the use of vedolizumab in pediatric patients with gastrointestinal acute GVHD, with 2 cases achieving resolution.